免疫抑制
医学
移植后淋巴增生性疾病
并发症
淋巴瘤
免疫疗法
BK病毒
肾病
多瘤病毒感染
移植
肾移植
免疫学
淋巴增殖性病變
器官移植
内科学
免疫系统
美罗华
糖尿病
内分泌学
作者
Faraz Khan,Maroun Khoury,Fahad Kouli,Aaron C. Han
出处
期刊:Emirates medical journal
[Bentham Science]
日期:2020-05-20
卷期号:2 (1): 45-49
标识
DOI:10.2174/0250688201999200520125625
摘要
Background: Post-transplant Lymphoproliferative Disorders (PTLD) are a well known late complication after solid organ transplantation, including renal transplant. Among others, graft failure due to reactivation of BK polyomavirus in the grafted kidney is also a well-recognized complication but tends to present early in the first several months after transplant. Case: Here we present the case of PTLD Burkitt's Lymphoma (BL-PTLD) in a renal transplant patient who was successfully treated with multiagent chemo-immunotherapy but later developed BK polyomavirus nephropathy (BKVN) with graft failure only after completion of her systemic therapy for lymphoma and 7 years after the transplant. Relevant literature is reviewed. Conclusion: In this case, reactivation and progression of BKVN were most likely associated with immunosuppression from chemo-immunotherapy for her BL–PTLD, unlike early graft failures associated with BKVN.
科研通智能强力驱动
Strongly Powered by AbleSci AI